NTRK2 and glaucoma: The observation that the CTB intensity was reduced in the distal optic nerve but maintained in the superior colliculus following administration of AAV2 TrkB-2A-mBDNF in the experimental glaucoma model could be explained by improved neuronal connectivity or regeneration at the level of the colliculus.